Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual Epinephrine Candidate

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

Very Low-Dose Multi-Nut OIT Promising for Children with Multiple Food Allergies

DBV to Submit FDA Application After Viaskin Peanut Patch Achieves Goals...

Mabylon Begins Human Clinical Trials of New Peanut Allergy Treatment

Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer

Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment

Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over...

Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children

RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food...

Fruit Power: How Pectin Prebiotics Could Offer a New Way to...

FDA Clears Moonlight Therapeutics to Begin Clinical Trial for Innovative Peanut...

Your School On Our Map

Put Your School on the Map